Andere Sprachen Catalent, Inc.

Aktien

Realtime-Estimate Cboe BZX Andere Börsenplätze 19:36:27 06.06.2024			% 5 Tage	% 1. Jan.
56,14 ^USD	+1,20 %		+4,53 %	+24,73 %

29.05.	Catalent-Aktionare genehmigen Deal mit Novo Holdings	MT
29.05.	Catalent-Aktionare stimmen dem Deal mit Novo Holdings zu	RE

Catalent Shareholders Approve Deal With Novo Holdings	29.05.
Catalent stockholders approve deal with Novo Holdings	29.05.
Catalent Stockholders Approve Transaction with Novo Holdings	29.05.
Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal	14.05.
Novo Nordisk Plans First Bond Sale in Two Years	14.05.
Novo Nordisk Plans First Bond Sale in 2 Years	13.05.
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	09.05.
Catalent: Fiscal Q3 Earnings Snapshot	09.05.
Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.07B	08.05.
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results	08.05.
Catalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	08.05.
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer	08.05.
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition	03.05.
Catalent, Novo Nordisk Antitrust Review Extended by FTC	03.05.
FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal	03.05.
US FTC seeks more information on Novo Nordisk parent-Catalent deal	03.05.
FTC seeks more information on Novo Holdings-Catalent deal	03.05.
Novo Nordisk baja el precio de su medicamento contra la obesidad debido a la competencia	02.05.
Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast	02.05.
Obesity drugmaker Novo Nordisk's Q1 profit beats forecast	02.05.

Keine Ergebnisse zu dieser Suche